Dermata Therapeutics Inc. Warrant (DRMAW) at a glance
Dermata Therapeutics Inc. Warrant (DRMAW) is a Healthcare company. It trades at $0, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 54/100 overall. Its strongest dimension is Safety (90/100) and its weakest is Momentum (12/100). It is a relatively defensive holding with below-market volatility.
- Price
- $0.00
- Market cap
- n/a
- P/E ratio
- n/a
- Dividend yield
- None
- Beta
- 0.66
- 52-week range
- $0.00 to $0.03
Value
58
Growth
50
Income
40
Safety
90
Momentum
12
Other Healthcare stocks
See allDHR.PR.A50
Danaher Corp
$1,841.01+0.00%
2.58% yield
LLY68
Eli Lilly and Company
$1,151.40-0.96%
0.57% yield
JNJ61
Johnson & Johnson
$270.27+0.73%
2.18% yield
ABBV46
AbbVie Inc.
$263.98-0.86%
2.96% yield
UNH56
UnitedHealth Group Incorporated
$375.83-0.34%
2.16% yield
MRK60
Merck & Co., Inc.
$147.17-0.98%
2.79% yield
ABT54
Abbott Laboratories
$102.23+0.92%
2.16% yield
AMGN65
Amgen Inc.
$379.76-1.05%
2.76% yield